Independent Medical Alliance - Latest News and Information
In this episode, senior fellow Jessica Rose discusses her forthcoming paper on the shortcomings of the U.S. Vaccine Adverse Event Reporting System (VAERS) and proposes a modernization framework. She highlights structural issues such as poor data quality, under‑reporting, lack of standardized inputs, and the inability to calculate incidence rates, which together cause significant signal loss. Using a 2021 VAERS dataset, she demonstrates a high proportional reporting ratio for Moderna‑related myocarditis and applies the Bradford Hill criteria, yielding a causality score of 9.76/10, while also showcasing AI tools that automate PRR calculations and causality assessments. Rose’s recommendations aim to make VAERS a more transparent, responsive, and real‑time pharmacovigilance tool for regulators and public‑health officials.
A federal judge issued a preliminary ruling overturning HHS Secretary Robert F. Kennedy Jr.’s changes to the Advisory Committee on Immunization Practice, blocking 13 new appointees and nullifying a plan to reduce the infant vaccine schedule. The decision preserves the...
Dr. Joseph Varon highlights a growing "procedural cascade" in modern medicine, where patients undergo a rapid series of tests and interventions often without clear stepwise justification. He attributes this trend to financial incentives, defensive medicine, and a decline in bedside...
A new peer‑reviewed chapter in the IntechOpen volume *Vaccine Development – Lessons Learned and Future Trends* proposes a three‑pronged biological model for post‑acute COVID‑19 vaccination syndrome (PACVS). The authors identify metabolic dysfunction, autoimmunity, and vascular damage as distinct mechanisms driving...
In this episode, Dr. Sabine Hazen discusses her lab’s pioneering 2020 study that identified full‑genome SARS‑CoV‑2 in patient stool samples, showing the virus can persist in the gut for weeks—and potentially years—after respiratory clearance. She explains how the findings revealed...
The Independent Medical Alliance (IMA) returned to Washington, D.C. in early February 2026 for a series of meetings with senators, congressional staff, HHS officials and national media. Representing more than 12,000 clinicians across 35 specialties, IMA presented frontline clinical data...
